MycoLogics, Inc. Moves Closer Towards The Discovery Of A San Joaquin Valley Fever Vaccine (Coccidioidomycosis)
10/19/2005 5:09:56 PM
MycoLogics, Inc., an innovative biotechnology company specializing in the development of therapeutic and prophylactic vaccines against human fungal and parasitic pathogens, today announced award of a Phase I SBIR grant by the Department of Health and Human Services to derive a novel vaccine against the emerging disease San Joaquin Valley Fever (Coccidioidomycosis). San Joaquin Valley Fever is a fungal disease caused by Coccidioides immitis, endemic in portions of California, Arizona, New Mexico and Texas, where more than five million people are residing in these at-risk regions.
comments powered by